Somalia has recorded a major medical milestone after Shaafi Hospital announced that it had successfully performed the country’s first two modern cochlear implant surgeries, introducing a specialised hearing treatment that was previously unavailable locally.
The procedures mark Somalia’s entry into a growing group of African countries offering cochlear implantation, with the hospital saying the achievement makes the country the ninth in Africa to introduce the technology.
In a press release issued on Tuesday, October 27, Shaafi Hospital said the operations were carried out by Dr Ismail Mohamed Ali, an Ear, Nose and Throat (ENT) specialist with particular expertise in ear surgery and cochlear implantation.
The hospital described the procedures as a significant step forward for Somalia’s healthcare sector, particularly in the treatment of people with severe hearing loss who may benefit from advanced hearing technology.
Shaafi Hospital said it was the first medical facility in Somalia to offer cochlear implant surgery, placing it at the forefront of the introduction of the specialised procedure in the country.
The achievement was made possible through a partnership between the hospital and MED-EL, an international manufacturer of cochlear implant devices.
The collaboration brought together the hospital’s medical team and specialised implant technology to carry out the procedures, according to the announcement.
Cochlear implants are electronic medical devices designed to help people with severe to profound hearing loss who may receive limited benefit from conventional hearing aids. Unlike hearing aids, which amplify sound, cochlear implants bypass damaged parts of the inner ear and electrically stimulate the auditory nerve.
The technology can provide access to sound and support speech understanding, although outcomes vary from one patient to another. Recipients may also require rehabilitation and training to learn how to interpret the sounds provided by the device.
What cochlear implants mean for patients
The introduction of the procedure in Somalia could create new options for people with significant hearing loss who previously had limited access to this form of specialised treatment within the country.
Patients seeking cochlear implantation may otherwise need to travel abroad to access the procedure, potentially adding travel expenses and other costs to an already specialised form of medical care. However, Shaafi Hospital’s announcement did not specify how much the surgeries cost or whether the service would be available to all patients who need it.
The hospital also did not disclose the identities or medical histories of the two patients, the causes of their hearing loss or the extent of their recovery following the operations.
Those details will be important in assessing the wider impact of the new service and the number of people who could benefit from it.
According to Shaafi Hospital, Somalia is now the ninth country in Africa to introduce cochlear implant surgery.
The development represents an expansion of the country’s specialised medical capabilities, as the hospital becomes the first facility locally to announce that it has performed the procedure.
The partnership with MED-EL was central to the achievement, bringing an international cochlear implant manufacturer into the effort to establish the service in Somalia.